Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin vs Rosuvastatin + Ezetimibe for Carotid Plaque Inflammation
NCT04056169Phase 4Completed
- Sponsor
- Yuhan
- Start
- Jun 2017
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ezetimibe in acute coronary syndrome (ACS), carotid artery disease, sponsored by Yuhan. Started Jun 2017; status: completed.
02
Drugs
ezetimibe
03
Conditions
acute coronary syndrome (ACS)carotid artery disease
Beyond the preview
Go deeper on NCT04056169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04056169.